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Malignant Hyperthermia
Emmanuel Mensah, CCRN, BSN, RN,
Otterbein University, Westerville, Ohio

What is your topic?
Malignant Hyperthermia- Malignant
hyperthermia is a rare, life-threatening
disorder triggered by the use of volatile
anesthetics agents such as succinylcholine
(Yang et al., 2020)

Pathophysiology
of Malignant
Hyperthermia
-
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The picture above describes the
step by step management for a
patient with MH based on the
MHAUS guidelines (Normandin
& Benotti, 2018)

Why Malignant
Hyperthermia?

-

Malignant Hyperthermia is due to
an uncontrolled amount of
calcium released from the
sarcoplasmic reticulum into the
myoplasm (Ravaei et al., 2020).
The uncontrolled release of
calcium can be due to potent
inhalation agent, a stressor such
as heat and exercise,
succinylcholine (muscle relaxant),
or a genetic mutation to the
ryanodine receptor (Ravaei et al.,
2020).
The Ryanoidne receptors(RyR1)
function to regulate the amount of
calcium being released into the
sarcoplasmic reticulum. When
there is a genetic mutation in
RyR1 an excessive amount of
calcium is released (Chen et al.,
2017). The large amount of
intracellular calcium leads to the
myocyte reaching threshold
quicker and maintain a contractile
state for a prolonged period.
Prolonged muscle contraction
leads to muscle rigidity which is
detrimental to an individual.
Muscle rigidity increases carbon
dioxide production, body
temperature, oxygen requirements
and exhaust ATP stores (Yang et
al., 2020)

Signs and Symptoms
•

A patient Malignant hyperthermia
presents with multiple signs and
symptoms
Hyperthermia, excessive sweating,
mottled skin (Mayo Clinic, 2021).

•

Muscle Rigidity, excessive bleeding,
tachycardia, masseter spasm (Cornelius et
al., 2020)

•

Abnormal Laboratory findings include
elevated myoglobin, calcium, potassium,
creatine phosphokinase and serum
myoglobin. (Sinha et al., 2017)

Treatment of MH includes two steps
Step 1: Immediate treatment
Step 1 involves stopping all triggering agents. If
possible, the surgery she be stopped, if this is not
possible then the procedure continue with the use of
non-triggering anesthetics.
-

-

- Maligngnat Hyperthermia is a rare
disorder that can turn fatal if not
recognized in a timely manner by a
provider (Cornelius et al., 2020)
-There are currently only two diagnostic
methods used for MH, more research is
needed to expand diagnostic methods and
validity (Yang, 2020)

Call for help and administer IV Dantrolene 2.5 mg/kg
rapidly (Cornelius et al., 2020)

Step 2: The second step involves symptomatic treatment.
Hyperkalemia should be treated with calcium chloride, calcium
gluconate or sodium bicarbonate (Yang, 2020). Hyperthermia is treated
with administration of 2,000 ml of cold crystalloid fluids (4 degrees
Celsius), if possible, the patient’s body should be packed with ice
packs or cooling pads

- Anesthetic education on malignant
hyperthermia should center around skills
that will better prepare the anesthetist to
provide adequate care to a patient
experienced MH (Kleidon, 2020).

Case Study
-

Case study outlines a 24-year
old male who presented to the
Ohio State University to receive
dental treatment (Cornelius et
al., 2020)

-

Pt received 200mg of
Succinylcholine, 150 mg of
propofol and 2% sevoflurane

-

15 minutes into the patients
arrival his heart rate increased
from 82 to 123 bpm and his
temperature increased to 38.9
(was 35. initially).

-

Clinicians noted the patients and
diagnosed the patient with MH

-

Help was called in and
interventions such as
administration of dantrolene,
placement of ice packs around
the individuals groin, axilla,
neck and chest area.

-

Paramedics were called and the
patient was transferred to the
emergency department and
eventually spent 4 days in the
intensive care department.

-

3 days later the patient was
discharged from the hospital and
made a complete recovery.
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-Malignant hyperthermia is estimated to
occur in between 1:10,000 and 1:150,000
anesthetic cases (Hopkins et al., 2021).
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- Malignant hyperthermia is estimated to
have a fatality rate of 9.5% (Yang et al.,
2021).

\'mtriailar

- MH commonly occurs when an
individual is having their initial contact
with anesthetic agents (Ravaei et al.,
2020).

-

•

Conclusion and
Implications

Nursing Care and Management
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The picture above displays
all the clinical symptoms of
MH and the percent of
patients who present with
that specific symptom
(Yang et al., 2020)

-

Step 2: The second step involves symptomatic
treatment. Hyperkalemia should be treated with calcium
chloride, calcium gluconate or sodium bicarbonate
(Yang, 2020). Hyperthermia is treated with
administration of 2,000 ml of cold crystalloid fluids (4
degrees Celsius), if possible, the patient’s body should
be packed with ice packs or cooling pads
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The picture above describes the treatment process for MH (Yang et al., 2020)

- Dantrolene is currently the only acute
treatment for MH; the use of dantrolene is
a poor long treatment as it can lead to
kidney and liver toxicity .

Significance of
Pathophysiology
-

Due to the severity of MH it is pertinent that
health care providers recognize the initial
signs and symptoms and treat the patient
appropriately (Miyazaki et al., 2021).

-

If not recognized immediately a patient can
develop irreversible kidney, liver and brain
damage.
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